HK Stock Market Move | VIGONVITA-B (02630) rose more than 5% intraday after receiving voluntary extensions of the lock-up period from all pre-IPO investors, including the controlling shareholder.

VIGONVITA-B (02630) rose more than 5% intraday, up 3.45% as of press time at HK$78, with turnover of HK$12.3166 million. On the news front, VIGONVITA-B announced that recently the Company received notices from all pre-IPO investors, including the controlling shareholder, pursuant to which, based on their high recognition of the Company's R&D pipeline value, the commercialization prospects of approved drugs, and the core management team, they have each undertaken not to reduce their respective shareholdings in the Company in any manner during an extended lock-up period of 7 months or 4 months from the expiry date of the original lock-up period (the "Extended Lock-up Period"). The Company believes that the Extended Lock-up Period demonstrates the aforementioned shareholders' full confidence in the Company's future prospects and long-term value.